Common ownership and market entry in the pharmaceutical industry
Albert Banal-Estañol, Melissa Newham, and Jo Seldeslachts provide evidence on the impact of common ownership on generic drug entry in US pharmaceutical markets.
Albert Banal-Estañol, Melissa Newham, and Jo Seldeslachts provide evidence on the impact of common ownership on generic drug entry in US pharmaceutical markets.
Antonio Penta discusses his ERC Starting Grant project in this short video.
Sandro Shelegia and Joshua Sherman undertake the first empirical study of the firm-side factors that influence the retail firm’s trading mechanism.
Christopher Hansman, Jonas Hjort, Gianmarco León, and Matthieu Teachout explain how exporters in developing countries use vertical integration to upgrade output quality and gain access to high end markets in the developed world.